JP2008546406A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008546406A5 JP2008546406A5 JP2008518189A JP2008518189A JP2008546406A5 JP 2008546406 A5 JP2008546406 A5 JP 2008546406A5 JP 2008518189 A JP2008518189 A JP 2008518189A JP 2008518189 A JP2008518189 A JP 2008518189A JP 2008546406 A5 JP2008546406 A5 JP 2008546406A5
- Authority
- JP
- Japan
- Prior art keywords
- implantable material
- composition
- cell
- cells
- cell population
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000463 material Substances 0.000 claims 71
- 210000004027 cell Anatomy 0.000 claims 57
- 239000000203 mixture Substances 0.000 claims 51
- 238000000034 method Methods 0.000 claims 20
- 239000006163 transport media Substances 0.000 claims 20
- 239000011159 matrix material Substances 0.000 claims 14
- 239000000090 biomarker Substances 0.000 claims 10
- 210000002889 endothelial cell Anatomy 0.000 claims 8
- 229920002971 Heparan sulfate Polymers 0.000 claims 7
- 238000004113 cell culture Methods 0.000 claims 7
- 230000003833 cell viability Effects 0.000 claims 7
- 230000002401 inhibitory effect Effects 0.000 claims 7
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 6
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 6
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 5
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 5
- 239000000758 substrate Substances 0.000 claims 5
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 5
- 239000012595 freezing medium Substances 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 238000005138 cryopreservation Methods 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 239000002245 particle Substances 0.000 claims 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims 2
- 229920002307 Dextran Polymers 0.000 claims 2
- 108010010803 Gelatin Proteins 0.000 claims 2
- 230000003698 anagen phase Effects 0.000 claims 2
- 230000008619 cell matrix interaction Effects 0.000 claims 2
- 239000012091 fetal bovine serum Substances 0.000 claims 2
- 230000009969 flowable effect Effects 0.000 claims 2
- 239000008273 gelatin Substances 0.000 claims 2
- 229920000159 gelatin Polymers 0.000 claims 2
- 235000019322 gelatine Nutrition 0.000 claims 2
- 235000011852 gelatine desserts Nutrition 0.000 claims 2
- 150000004676 glycans Chemical class 0.000 claims 2
- 230000007774 longterm Effects 0.000 claims 2
- 210000004962 mammalian cell Anatomy 0.000 claims 2
- 239000013028 medium composition Substances 0.000 claims 2
- 229920001282 polysaccharide Polymers 0.000 claims 2
- 239000005017 polysaccharide Substances 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 210000000130 stem cell Anatomy 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 claims 1
- 108010035532 Collagen Proteins 0.000 claims 1
- 102000009123 Fibrin Human genes 0.000 claims 1
- 108010073385 Fibrin Proteins 0.000 claims 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims 1
- 229920000954 Polyglycolide Polymers 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 1
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 claims 1
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 claims 1
- 229940072056 alginate Drugs 0.000 claims 1
- 235000010443 alginic acid Nutrition 0.000 claims 1
- 229920000615 alginic acid Polymers 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- 229920001577 copolymer Polymers 0.000 claims 1
- 229960002086 dextran Drugs 0.000 claims 1
- 229950003499 fibrin Drugs 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 210000005260 human cell Anatomy 0.000 claims 1
- 239000003094 microcapsule Substances 0.000 claims 1
- -1 microcarrier Substances 0.000 claims 1
- 229920000747 poly(lactic acid) Polymers 0.000 claims 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 229940006186 sodium polystyrene sulfonate Drugs 0.000 claims 1
- 229940099456 transforming growth factor beta 1 Drugs 0.000 claims 1
- 230000023750 transforming growth factor beta production Effects 0.000 claims 1
- 230000007704 transition Effects 0.000 claims 1
- 210000003556 vascular endothelial cell Anatomy 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69270805P | 2005-06-21 | 2005-06-21 | |
| US60/692,708 | 2005-06-21 | ||
| USPCT/US2005/043967 | 2005-12-06 | ||
| PCT/US2005/043967 WO2006062909A2 (en) | 2004-12-08 | 2005-12-06 | Methods and compositions for enhancing vascular access |
| PCT/US2006/021755 WO2007001744A2 (en) | 2005-06-21 | 2006-06-05 | Methods and compositions for enhancing vascular access |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012133043A Division JP2012166084A (ja) | 2005-06-21 | 2012-06-12 | 脈管アクセスを改善するための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008546406A JP2008546406A (ja) | 2008-12-25 |
| JP2008546406A5 true JP2008546406A5 (enExample) | 2009-07-16 |
| JP5632580B2 JP5632580B2 (ja) | 2014-11-26 |
Family
ID=39892157
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008518189A Expired - Fee Related JP5632580B2 (ja) | 2005-06-21 | 2006-06-05 | 脈管アクセスを改善するための方法および組成物 |
| JP2012133043A Withdrawn JP2012166084A (ja) | 2005-06-21 | 2012-06-12 | 脈管アクセスを改善するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012133043A Withdrawn JP2012166084A (ja) | 2005-06-21 | 2012-06-12 | 脈管アクセスを改善するための方法および組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20090035346A1 (enExample) |
| EP (2) | EP2361591A3 (enExample) |
| JP (2) | JP5632580B2 (enExample) |
| CN (3) | CN102743792B (enExample) |
| AU (1) | AU2006262682B2 (enExample) |
| CA (2) | CA2818182C (enExample) |
| ES (1) | ES2541684T3 (enExample) |
| IL (2) | IL188263A (enExample) |
| SG (2) | SG161258A1 (enExample) |
| WO (1) | WO2007001744A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2926510B2 (ja) | 1990-08-09 | 1999-07-28 | 京都電子工業株式会社 | アンモニア濃度測定装置 |
| EP1874919B1 (en) | 2005-04-21 | 2010-06-09 | Massachusetts Institute Of Technology | Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs |
| CN102743792B (zh) | 2005-06-21 | 2014-09-24 | 夏尔再生医学公司 | 用于增强血管通路的方法和组合物 |
| WO2008057590A2 (en) * | 2006-11-07 | 2008-05-15 | Pervasis Therapeutics, Inc. | Methods and compositions for modulating tissue modeling |
| SG176460A1 (en) * | 2006-11-07 | 2011-12-29 | Pervasis Therapeutics Inc | Materials and methods for treating and managing angiogenesis-mediated diseases |
| WO2009097218A1 (en) | 2008-01-28 | 2009-08-06 | Biomet 3I, Llc | Implant surface with increased hydrophilicity |
| CA2834040C (en) | 2011-04-28 | 2020-01-14 | Abraxis Bioscience, Llc | Intravascular delivery of nanoparticle compositions and uses thereof |
| CN102763642B (zh) * | 2012-08-14 | 2014-04-02 | 郑州赛英科干细胞技术有限公司 | 一种冷冻保护液以及冷冻保存人胎盘羊膜和绒毛膜的方法 |
| EP3148601A1 (en) * | 2014-05-27 | 2017-04-05 | Novahep AB | Bioengineered allogeneic valve |
| JP6830911B2 (ja) * | 2015-03-10 | 2021-02-17 | ステント・テック・リミテッドＳｔｅｎｔ Ｔｅｋ Ｌｉｍｉｔｅｄ | 自己血管使用皮下動静脈瘻（ａｖｆ）の経皮作成用の外科システムおよび外科デバイス |
| US12017032B1 (en) | 2017-11-13 | 2024-06-25 | Sbr Innovations, Llc | Arteriovenous graft and method of using thereof |
| US11389622B1 (en) * | 2017-11-13 | 2022-07-19 | Simon B. Rayhanabad | Patch for providing dialysis |
| US11918223B2 (en) | 2018-02-02 | 2024-03-05 | University Of Louisville Research Foundation, Inc. | Sutureless graft anastomotic quick connect system |
| WO2020047380A1 (en) * | 2018-08-31 | 2020-03-05 | Wisconsin Alumni Research Foundation | Generating arterial endothelial cell-seeded vascular grafts |
| US12310836B2 (en) | 2020-03-03 | 2025-05-27 | Akeo Hagiwara | Vein cover |
| CN115376392B (zh) * | 2022-08-18 | 2024-04-26 | 昆明理工大学 | 主动脉老化对血管生物力学影响的模拟装置及方法 |
| EP4439070B1 (de) * | 2023-03-27 | 2025-12-03 | Siemens Healthcare Diagnostics Products GmbH | Automatisches analysesystem |
| CN120227529B (zh) * | 2025-05-29 | 2025-08-12 | 鼎科医疗技术（苏州）有限公司 | 一种血管外支架 |
Family Cites Families (88)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4418691A (en) * | 1981-10-26 | 1983-12-06 | Massachusetts Institute Of Technology | Method of promoting the regeneration of tissue at a wound |
| US4787900A (en) * | 1982-04-19 | 1988-11-29 | Massachusetts Institute Of Technology | Process for forming multilayer bioreplaceable blood vessel prosthesis |
| US4820626A (en) * | 1985-06-06 | 1989-04-11 | Thomas Jefferson University | Method of treating a synthetic or naturally occuring surface with microvascular endothelial cells, and the treated surface itself |
| IL78950A (en) | 1985-06-06 | 1991-12-15 | Univ Jefferson | Coating for prosthetic devices |
| US4732155A (en) * | 1985-08-27 | 1988-03-22 | The Children's Medical Center Corporation | Implantable chemoattractant system |
| US5863531A (en) * | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
| US6309635B1 (en) * | 1986-11-20 | 2001-10-30 | Children's Medical Center Corp. | Seeding parenchymal cells into compression resistant porous scaffold after vascularizing in vivo |
| US5567612A (en) * | 1986-11-20 | 1996-10-22 | Massachusetts Institute Of Technology | Genitourinary cell-matrix structure for implantation into a human and a method of making |
| US5736372A (en) * | 1986-11-20 | 1998-04-07 | Massachusetts Institute Of Technology | Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure |
| CA1340581C (en) * | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
| US5804178A (en) * | 1986-11-20 | 1998-09-08 | Massachusetts Institute Of Technology | Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue |
| US5073492A (en) * | 1987-01-09 | 1991-12-17 | The Johns Hopkins University | Synergistic composition for endothelial cell growth |
| US5145769A (en) * | 1987-08-21 | 1992-09-08 | Cryolife Inc. | Method for cryopreserving blood vessels |
| US5202120A (en) * | 1987-09-11 | 1993-04-13 | Case Western Reserve University | Methods of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes |
| US4945086A (en) | 1988-05-03 | 1990-07-31 | The Board Of Trustees Of The Leland Stanford Junior University | Smooth muscle cell growth inhibitor |
| US5843156A (en) * | 1988-08-24 | 1998-12-01 | Endoluminal Therapeutics, Inc. | Local polymeric gel cellular therapy |
| US5575815A (en) * | 1988-08-24 | 1996-11-19 | Endoluminal Therapeutics, Inc. | Local polymeric gel therapy |
| CH676195A5 (enExample) * | 1988-10-07 | 1990-12-28 | Sulzer Ag | |
| JPH03133901A (ja) * | 1989-10-19 | 1991-06-07 | Osaka Gas Co Ltd | 生体細胞の凍結保存方法 |
| US5527532A (en) * | 1989-11-13 | 1996-06-18 | President And Fellows Of Harvard College | Extraluminal regulation of the growth and repair of tubular structures in vivo |
| WO1991007154A1 (en) * | 1989-11-13 | 1991-05-30 | President And Fellows Of Harvard College | EXTRALUMINAL REGULATION OF THE GROWTH AND REPAIR OF TUBULAR STRUCTURES ιIN VIVO |
| US5540928A (en) * | 1991-02-27 | 1996-07-30 | President And Fellows Of Harvard College | Extraluminal regulation of the growth and repair of tubular structures in vivo |
| CA2071137A1 (en) * | 1991-07-10 | 1993-01-11 | Clarence C. Lee | Composition and method for revitalizing scar tissue |
| CA2113089C (en) | 1991-07-15 | 2007-11-06 | Peter J. Sims | Universal donor cells |
| US5336615A (en) | 1992-01-06 | 1994-08-09 | Yale University | Genetically engineered endothelial cells exhibiting enhanced migration and plasminogen activator activity |
| JPH0646840A (ja) * | 1992-08-04 | 1994-02-22 | Nippon Zenyaku Kogyo Kk | 細胞凍結保存液 |
| US5399665A (en) * | 1992-11-05 | 1995-03-21 | Massachusetts Institute Of Technology | Biodegradable polymers for cell transplantation |
| US5981568A (en) * | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6491938B2 (en) * | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| GB9306449D0 (en) * | 1993-03-29 | 1993-05-19 | Nat Heart Research Fund | Tissue equivalents |
| US5709854A (en) * | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
| US5645829A (en) * | 1993-06-18 | 1997-07-08 | Beth Israel Hospital Association | Mesothelial cell gene therapy |
| US6176874B1 (en) * | 1993-10-18 | 2001-01-23 | Masschusetts Institute Of Technology | Vascularized tissue regeneration matrices formed by solid free form fabrication techniques |
| US6608182B1 (en) * | 1994-03-08 | 2003-08-19 | Human Genome Sciences, Inc. | Human vascular endothelial growth factor 2 |
| CA2186375A1 (en) | 1994-04-29 | 1995-11-09 | William Carl Bruchman | Improved blood contact surfaces using endothelium on a subendothelial extracellular matrix |
| US5834029A (en) * | 1994-07-20 | 1998-11-10 | Cytotherapeutics, Inc. | Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment |
| EP1004293A3 (en) * | 1994-10-12 | 2001-10-04 | Focal, Inc. | Targeted delivery via biodegradable polymers |
| US6911216B1 (en) * | 1994-10-12 | 2005-06-28 | Genzyme Corporation | Targeted delivery via biodegradable polymers |
| US5914268A (en) * | 1994-11-21 | 1999-06-22 | National Jewish Center For Immunology & Respiratory Medicine | Embryonic cell populations and methods to isolate such populations |
| US6281015B1 (en) * | 1994-12-16 | 2001-08-28 | Children's Medical Center Corp. | Localized delivery of factors enhancing survival of transplanted cells |
| US5716404A (en) * | 1994-12-16 | 1998-02-10 | Massachusetts Institute Of Technology | Breast tissue engineering |
| US5855610A (en) * | 1995-05-19 | 1999-01-05 | Children's Medical Center Corporation | Engineering of strong, pliable tissues |
| US5766584A (en) * | 1995-06-02 | 1998-06-16 | Massachusetts Institute Of Technology | Inhibition of vascular smooth muscle cell proliferation with implanted matrix containing vascular endothelial cells |
| US6615071B1 (en) * | 1995-09-20 | 2003-09-02 | Board Of Regents, The University Of Texas System | Method and apparatus for detecting vulnerable atherosclerotic plaque |
| US5897987A (en) * | 1996-03-25 | 1999-04-27 | Advanced Reproduction Technologies, Inc. | Use of arabinogalactan in cell cryopreservation media |
| US6886568B2 (en) * | 1998-04-08 | 2005-05-03 | The Johns Hopkins University | Method for fabricating cell-containing implants |
| CA2351671A1 (en) * | 1998-11-24 | 2000-06-08 | Regents Of The University Of Minnesota | Transgenic circulating endothelial cells |
| US6328762B1 (en) * | 1999-04-27 | 2001-12-11 | Sulzer Biologics, Inc. | Prosthetic grafts |
| US6387116B1 (en) * | 1999-06-30 | 2002-05-14 | Pharmasonics, Inc. | Methods and kits for the inhibition of hyperplasia in vascular fistulas and grafts |
| US6461631B1 (en) * | 1999-11-16 | 2002-10-08 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
| WO2001062241A1 (en) * | 2000-02-23 | 2001-08-30 | Smithkline Beecham Corporation | Method for the prevention or reduction of vascular access dysfunction |
| ATE373682T1 (de) * | 2000-03-13 | 2007-10-15 | Biocure Inc | Embolische zusammensetzungen |
| IL151501A0 (en) * | 2000-03-15 | 2003-04-10 | Orbus Medical Technologies Inc | Coating that promotes endothelial cell adherence |
| EP1269840A4 (en) | 2000-03-24 | 2009-05-06 | Menicon Co Ltd | METHOD FOR PRESERVING A TISSUE TREATMENT AND IN THE FROZEN CONSERVATED TISSUE REPLACEMENT |
| US6506398B1 (en) * | 2000-04-28 | 2003-01-14 | Hosheng Tu | Device for treating diabetes and methods thereof |
| AU2001275392A1 (en) * | 2000-06-09 | 2001-12-24 | Organ Recovery Systems | Cryopreservation method using cryoprotective composition of propanediol and a vehicle solution |
| EP1301197A2 (en) | 2000-07-21 | 2003-04-16 | The Board Of Regents, The University Of Texas System | Device providing regulated growth factor delivery for the regeneration of peripheral nerves |
| US6696483B2 (en) * | 2000-10-03 | 2004-02-24 | Oncopharmaceutical, Inc. | Inhibitors of angiogenesis and tumor growth for local and systemic administration |
| JP2002200161A (ja) * | 2000-10-24 | 2002-07-16 | Menicon Co Ltd | 培養皮膚代替物の製造方法およびそれにより得られる培養皮膚代替物 |
| US6565601B2 (en) * | 2000-11-15 | 2003-05-20 | Micro Therapeutics, Inc. | Methods for vascular reconstruction of diseased arteries |
| EP1389078A4 (en) * | 2000-12-27 | 2004-03-17 | Ortec International Inc | METHOD FOR THE PRODUCTION OF CRYCONSERVED COMPOSED LIVING CONSTRUCTS AND PRODUCTS PRODUCED FROM THEM |
| ATE481097T1 (de) * | 2001-01-16 | 2010-10-15 | Vascular Therapies Llc | Implantierbare vorrichtung enthaltend resorbierbares matrixmaterial und antiproliferative wirkstoffe zur vorbeugung oder behandlung von versagen vaskulärer hämodialysezugänge und anderer vaskulärer transplantate |
| US6723131B2 (en) * | 2001-02-28 | 2004-04-20 | The Cleveland Clinic Foundation | Composite bone marrow graft material with method and kit |
| AU2002330131A1 (en) | 2001-09-28 | 2003-04-07 | Goldberg, Eugene, P. | Biopolymer and biopolymer-cell compositions for nerve tissue repair |
| US7297540B2 (en) * | 2002-01-15 | 2007-11-20 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Methods of generating tissue using devitalized, acellular scaffold matrices derived from micro-organs |
| US20040047843A1 (en) * | 2002-02-12 | 2004-03-11 | Uab Research Foundation | Method for spinal cord reconnection |
| US20050147959A1 (en) * | 2002-03-25 | 2005-07-07 | Frondoza Carmelita G. | Tissue analogs for in vitro testing and method of use therefor |
| US20050008629A1 (en) * | 2002-05-08 | 2005-01-13 | Interpore Orthopaedics, A Delaware Corporation | Encapsulated AGF cells |
| JP2005537822A (ja) * | 2002-06-28 | 2005-12-15 | ノバルティス アクチエンゲゼルシャフト | 有機化合物の使用 |
| FR2845691B1 (fr) * | 2002-10-10 | 2004-12-10 | Centre Nat Rech Scient | Nouvelles cellules endotheliales, anticorps diriges contre ces cellules et leur utilisation, notamment pour le criblage de substances inhibant l'angiogenese |
| US20040156878A1 (en) * | 2003-02-11 | 2004-08-12 | Alireza Rezania | Implantable medical device seeded with mammalian cells and methods of treatment |
| WO2004111207A1 (en) * | 2003-06-09 | 2004-12-23 | Centelion | Multicellular in vitro model of angiogenesis and methods for using the same |
| US8192348B2 (en) * | 2003-07-01 | 2012-06-05 | Regents Of The University Of Minnesota | Engineered blood vessels |
| GB0322789D0 (en) * | 2003-09-30 | 2003-10-29 | Lifeforce Group Plc | Blood pack for leukocyte banking |
| US20050106554A1 (en) * | 2003-11-19 | 2005-05-19 | Palecek Sean P. | Cryopreservation of pluripotent stem cells |
| US8067368B2 (en) * | 2004-01-27 | 2011-11-29 | The Ohio State University Research Foundation | Vascular endothelial growth factors and methods of their use |
| CN101080486B (zh) * | 2004-04-23 | 2012-05-16 | 佰欧益股份有限公司 | 多谱系祖细胞 |
| FR2869533B1 (fr) | 2004-05-03 | 2006-07-28 | Sedat Sa | Seringue pour interventions medicales et necessaire de reconstitution de substances extemporanees comportant une telle seringue |
| US7842304B2 (en) | 2004-10-29 | 2010-11-30 | Nexeon Medsystems, Inc. | Methods and apparatus for treating an injured nerve pathway |
| WO2006062909A2 (en) * | 2004-12-08 | 2006-06-15 | Pervasis Therapeutics, Inc. | Methods and compositions for enhancing vascular access |
| CA2589597C (en) | 2004-12-08 | 2015-04-21 | Pervasis Therapeutics, Inc. | Methods and compositions for enhancing vascular access |
| WO2006062871A2 (en) | 2004-12-08 | 2006-06-15 | Pervasis Therapeutics, Inc. | Materials and methods for minimally-invasive administration of a cell-containing flowable composition |
| EP1874919B1 (en) | 2005-04-21 | 2010-06-09 | Massachusetts Institute Of Technology | Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs |
| GB0509845D0 (en) | 2005-05-13 | 2005-06-22 | Btg Int Ltd | Preparation of therapeutic foam |
| CN102743792B (zh) | 2005-06-21 | 2014-09-24 | 夏尔再生医学公司 | 用于增强血管通路的方法和组合物 |
| KR20080070820A (ko) | 2005-10-12 | 2008-07-31 | 셀룰라 바이오엔지니어링 인코포레이티드 | 재흡수성 각막편 |
| WO2007053799A2 (en) * | 2005-10-19 | 2007-05-10 | Cd Solutions, Llc | Apparatus and method for mixing and transferring medications |
| CA2628339C (en) * | 2005-11-07 | 2015-04-28 | Industrie Borla S.P.A. | Vented safe handling vial adapter |
-
2006
- 2006-06-05 CN CN201210246619.1A patent/CN102743792B/zh not_active Expired - Fee Related
- 2006-06-05 SG SG201002482-6A patent/SG161258A1/en unknown
- 2006-06-05 AU AU2006262682A patent/AU2006262682B2/en not_active Ceased
- 2006-06-05 EP EP20110001333 patent/EP2361591A3/en not_active Withdrawn
- 2006-06-05 CN CN2006800279776A patent/CN101257861B/zh not_active Expired - Fee Related
- 2006-06-05 JP JP2008518189A patent/JP5632580B2/ja not_active Expired - Fee Related
- 2006-06-05 SG SG2013075387A patent/SG195537A1/en unknown
- 2006-06-05 CA CA 2818182 patent/CA2818182C/en not_active Expired - Fee Related
- 2006-06-05 US US11/922,729 patent/US20090035346A1/en not_active Abandoned
- 2006-06-05 ES ES06772165.4T patent/ES2541684T3/es active Active
- 2006-06-05 CN CN2010102362140A patent/CN101878757A/zh active Pending
- 2006-06-05 EP EP20060772165 patent/EP1901680B1/en not_active Not-in-force
- 2006-06-05 CA CA 2612751 patent/CA2612751A1/en not_active Abandoned
- 2006-06-05 WO PCT/US2006/021755 patent/WO2007001744A2/en not_active Ceased
-
2007
- 2007-12-19 IL IL188263A patent/IL188263A/en not_active IP Right Cessation
-
2012
- 2012-06-12 JP JP2012133043A patent/JP2012166084A/ja not_active Withdrawn
- 2012-07-05 IL IL220806A patent/IL220806A/en not_active IP Right Cessation
- 2012-11-02 US US13/667,227 patent/US9023377B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008546406A5 (enExample) | ||
| Li et al. | Culture of hepatocytes on fructose-modified chitosan scaffolds | |
| Koebe et al. | A new approach to the cryopreservation of hepatocytes in a sandwich culture configuration | |
| Elçin et al. | Hepatocyte attachment on biodegradable modified chitosan membranes: in vitro evaluation for the development of liver organoids | |
| Zavan et al. | Extracellular matrix-enriched polymeric scaffolds as a substrate for hepatocyte cultures: in vitro and in vivo studies | |
| JP5271076B2 (ja) | 新規な細胞組成物およびその調製方法 | |
| Ijima et al. | Liver-specific extracellular matrix hydrogel promotes liver-specific functions of hepatocytes in vitro and survival of transplanted hepatocytes in vivo | |
| JP4243638B2 (ja) | 細胞の保存 | |
| Hsu et al. | The effect of dynamic culture conditions on endothelial cell seeding and retention on small diameter polyurethane vascular grafts | |
| CN107988158B (zh) | 一种三维肿瘤模型脱细胞多孔支架、构建方法及其应用 | |
| CN102036555A (zh) | 移植物存储 | |
| JPWO2011016423A1 (ja) | 膵島細胞シート、製造方法及びその利用方法 | |
| JP2020516257A (ja) | 凍結保存方法 | |
| Kilbride et al. | Spatial considerations during cryopreservation of a large volume sample | |
| Lloyd et al. | Cryopreservation of hepatocytes: a review of current methods for banking | |
| JP2008501320A5 (enExample) | ||
| McGuigan et al. | Modular tissue engineering: fabrication of a gelatin‐based construct | |
| WO2007001744B1 (en) | Methods and compositions for enhancing vascular access | |
| JP2025126344A (ja) | 凍結された腎臓細胞の製造方法及び凍結された腎臓細胞 | |
| Hang et al. | In vitro analysis of cryopreserved alginate–poly‐l‐lysine–alginate‐microencapsulated human hepatocytes | |
| CN102559581A (zh) | 一种无血清肝细胞培养基 | |
| JP2007306856A (ja) | 細胞凍結保存方法 | |
| JPWO2017187941A1 (ja) | 凍結細胞集塊及び凍結細胞集塊の製造方法 | |
| JP4927089B2 (ja) | 肝細胞の凍結保存 | |
| JPH0577389B2 (enExample) |